Skip to content

Comparison of 3 doses of anesthetic for spinal anesthesia in cesarean section

A comparison study of different doses of isobaric Ropivacaine 0.5% in spinal anesthesia in cesarean section

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130812014333N156
Enrollment
108
Registered
2020-12-13
Start date
2020-11-10
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean delivery. Newborn (suspected to be) affected by Cesarean delivery

Interventions

Intervention 1: The first intervention group will receive 20 mg of ropivacaine 0.5% isobaric from MOLTENI company by injection. Intervention 2: The second intervention group will receive 22.5 mg of ro

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 42 Years

Inclusion criteria

Inclusion criteria: Cesarean section patients between 18 and 42 years old Weight between 60 to 90 kg Height between 155 and 175 Gestational age equal or greater than 36 weeks

Exclusion criteria

Exclusion criteria: History of coagulation problems Increased intracranial pressure Local anesthetic allergy Infection at the site of needle entry

Design outcomes

Primary

MeasureTime frame
Patient satisfaction with spinal anesthesia. Timepoint: After surgery. Method of measurement: Question from the patient (excellent, good, average, bad).;Blood pressure. Timepoint: Every 3 minutes from the start of the block until the recovery clearance. Method of measurement: Monitoring device.;Heart rate. Timepoint: Every 3 minutes from the start of the block until the recovery clearance. Method of measurement: Monitoring device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNahid Presidend

Kermanshah University of Medical Sciences

nahidpresidend65@Gmail.com+98 83 3427 4618

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026